{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "18522219", "DateCompleted": {"Year": "2008", "Month": "06", "Day": "30"}, "DateRevised": {"Year": "2014", "Month": "04", "Day": "01"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "2310-6972", "JournalIssue": {"Volume": "54", "Issue": "2", "PubDate": {"Year": "2008", "Season": "Mar-Apr"}}, "Title": "Biomeditsinskaia khimiia", "ISOAbbreviation": "Biomed Khim"}, "ArticleTitle": "[Proteolytic enzymes--a highly sensitive criterium for effectiveness and safety of treatment].", "Pagination": {"StartPage": "179", "EndPage": "183", "MedlinePgn": "179-83"}, "Abstract": {"AbstractText": ["The effect of ozonated saline on proteolytic enzymes: trypsin, chymotrypsin, elastase, kallikrein, leucine aminopeptidase, inhibitors of proteolysis and lipid peroxidation has been investigated. Injection of ozonated saline led to significal response of proteolytic system. Ozonated saline with low ozone doses produced a positive effect on proteolytic system. High doses of ozone produced significal reinforcement of proteolytic system and the decrease of alpha1-antitrypsin and alpha2-macroglobulin activity in blood plasma. Therefore, analyses of proteolytic activity can be used as indicator of effectiveness and safety of ozonetherapy and others treatment programms."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Efremenko", "ForeName": "Iu R", "Initials": "IuR"}], "PublicationTypeList": ["English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Biomed Khim", "NlmUniqueID": "101196966", "ISSNLinking": "2310-6905"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Peptide Hydrolases"}, {"RegistryNumber": "EC 3.4.11.1", "NameOfSubstance": "Leucyl Aminopeptidase"}, {"RegistryNumber": "EC 3.4.21.-", "NameOfSubstance": "Kallikreins"}, {"RegistryNumber": "EC 3.4.21.1", "NameOfSubstance": "Chymotrypsin"}, {"RegistryNumber": "EC 3.4.21.36", "NameOfSubstance": "Pancreatic Elastase"}, {"RegistryNumber": "EC 3.4.21.4", "NameOfSubstance": "Trypsin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Chymotrypsin"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Intestine, Small"}, {"QualifierName": ["metabolism"], "DescriptorName": "Kallikreins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Leucyl Aminopeptidase"}, {"QualifierName": [], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["adverse effects", "pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Pancreas"}, {"QualifierName": ["metabolism"], "DescriptorName": "Pancreatic Elastase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptide Hydrolases"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["metabolism"], "DescriptorName": "Trypsin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "6", "Day": "5", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "7", "Day": "1", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "6", "Day": "5", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18522219"]}}], "PubmedBookArticle": []}